Add BrightSurf on Google Email

Some male breast cancer patients may have unnecessary radiotherapy

A study of 60 male and 4,181 female breast cancer patients found that men were almost six times more likely to receive radiotherapy than women with similar disease stages. The researchers concluded that men should be treated using the same guidelines as women for radiotherapy treatment.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateJun 21, 2005

Cutting-edge cancer researchers sought for international recognition

The American Association for Cancer Research is accepting nominations for the 2005 Landon-AACR prizes, which recognize seminal basic and translational cancer research discoveries. The recipient of each prize will receive a $200,000 unrestricted cash award and present a lecture at the 96th AACR Annual Meeting in Anaheim, Calif.

SourceAmerican Association for Cancer Research·DateJul 23, 2004
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Should nurses conduct breast cancer follow-up visits?

A survey of Swedish breast cancer patients found that women prefer follow-up visits at breast centers rather than with their GP, but want more time for discussion. The study suggests that nurse-led follow-ups could increase patient satisfaction and reduce healthcare costs.

SourceECCO-the European CanCer Organisation·DateMar 18, 2004

New report shows stomach cancer rates declining fast in Europe

A recent report shows a significant decline in stomach cancer rates across Europe, with falls seen in younger and middle-aged populations. The downward trend is attributed to improved diet, better food preservation, reduced Helicobacter pylori infection, and lower smoking rates.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateFeb 2, 2004
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Herceptin gives disappointing results in lung cancer trial

A Phase II trial of Herceptin combined with chemotherapy found no significant difference in survival times between the treatment and control arms. However, a small subgroup of patients with extremely high levels of HER2 over-expression showed improved response rates and longer disease progression-free periods.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateJan 12, 2004

Wanted: Help through the jungle of hospital care

The Lancet editorial highlights the need for improved patient and family support in hospitals, citing a tragic case of a chronically ill child's experience. The authors propose increasing liaison staff to at least two per ward to provide emotional wellbeing support and reduce stories like Michaela's in the medical community.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 11, 2003

Study finds even healthcare professionals are sun worshipers

A study by cancer nurse Kerry Guile found that even oncologists and cancer nurses with high knowledge of sun protection were not acting on it. The sample size was 340 people, including medical students and non-oncology nurses, who scored highly on sun protective behavior.

SourceECCO-the European CanCer Organisation·DateSep 22, 2003
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Elderly patients denied best treatment for fear of side effects

A study involving 83 elderly women found that patients with depression, limited autonomy, and institutional living are at risk of toxicity and reduced treatment effectiveness. Dr. Gilles Freyer's research aims to evaluate risks and benefits for elderly patients with advanced ovarian cancer.

SourceEuropean Society for Medical Oncology·DateOct 20, 2002

European trial finds old lung cancer treatment may still be best

A new phase III multi-national European trial involving 618 patients with advanced non small-cell lung cancer found that cisplatin and paclitaxel improved survival rates compared to carboplatin and paclitaxel. The study suggests that cisplatin-based chemotherapy remains the preferred standard treatment for lung cancer in Europe.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateOct 9, 2002

Jefferson scientists find Cox-2 may play role in some brain tumors

Researchers at Thomas Jefferson University found that COX-2 expression is higher than normal in meningioma and pituitary macroadenomas, with more aggressive disease associated with greater enzyme presence. The study opens up opportunities for designing potential therapies against brain tumors.

SourceThomas Jefferson University·DateMay 21, 2002
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

The Lancet Oncology and The Lancet Infectious Diseases

A recent report highlights nuclear fallout in the US from Cold War testing, which increases cancer incidence and affects global populations. The editorial also critiques South Africa's delay in providing antiretroviral treatment to pregnant women with HIV.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 1, 2002